XTX Topco’s Oric Pharmaceuticals ORIC Stock Holding History

XTX Topco’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.36M	Buy	217,827 +174,536	+403%	+$1.58M	0.03%	948
2026 Q1	$548K	Sell	43,291 -67,274	-61%	-$764K	0.01%	1968
2025 Q4	$904K	Buy	+110,565	New	+$1.27M	0.02%	1096
2025 Q2	–	Sell	-19,077	Closed	-$106K	–	2952
2025 Q1	$106K	Sell	19,077 -6,889	-27%	-$60.2K	0.01%	1858
2024 Q4	$210K	Buy	25,966 +14,209	+121%	+$130K	0.02%	1519
2024 Q3	$121K	Sell	11,757 -9,881	-46%	-$97.7K	0.01%	1573
2024 Q2	$153K	Buy	+21,638	New	+$194K	0.01%	1322
2023 Q4	–	Sell	-11,320	Closed	-$68.5K	–	1973
2023 Q3	$68.5K	Buy	+11,320	New	+$92.8K	0.01%	1233
2022 Q4	–	Sell	-38,411	Closed	-$123K	–	1400
2022 Q3	$123K	Buy	38,411 +18,052	+89%	+$72.3K	0.03%	906
2022 Q2	$91K	Buy	+20,359	New	+$81.2K	0.04%	665

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

XTX Topco's ORIC Position: Q2 2026 in Review

XTX Topco increased its Oric Pharmaceuticals (ORIC) stake by 403% in Q2 2026, buying an estimated $1.58M and bringing the position to 217,827 shares worth $2.36M. The position accounts for 0.03% of the portfolio, ranked #948.

XTX Topco first reported a position in ORIC in Q2 2022 and has held it in 10 quarters since. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

XTX Topco held 217,827 shares of Oric Pharmaceuticals worth $2.36M as of Q2 2026.
XTX Topco bought 174,536 Oric Pharmaceuticals shares in Q2 2026, an estimated $1.58M.
Oric Pharmaceuticals made up 0.03% of XTX Topco's portfolio in Q2 2026, its #948 holding.
XTX Topco first reported a position in Oric Pharmaceuticals in Q2 2022 and has held it in 10 quarters since.
180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.